1. Home
  2. CCII vs MASS Comparison

CCII vs MASS Comparison

Compare CCII & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CCII

Cohen Circle Acquisition Corp. II Class A Ordinary Shares

N/A

Current Price

$10.32

Market Cap

358.7M

Sector

N/A

ML Signal

N/A

Logo 908 Devices Inc.

MASS

908 Devices Inc.

N/A

Current Price

$9.49

Market Cap

364.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCII
MASS
Founded
2024
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
358.7M
364.3M
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
CCII
MASS
Price
$10.32
$9.49
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
62.1K
452.2K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
125.47
EPS
N/A
N/A
Revenue
N/A
$56,197,000.00
Revenue This Year
N/A
$19.44
Revenue Next Year
N/A
$18.63
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.10
$5.03
52 Week High
$10.50
$11.25

Technical Indicators

Market Signals
Indicator
CCII
MASS
Relative Strength Index (RSI) 48.10 42.97
Support Level $10.32 $7.64
Resistance Level $10.50 $10.52
Average True Range (ATR) 0.01 0.49
MACD -0.00 -0.22
Stochastic Oscillator 33.33 1.56

Price Performance

Historical Comparison
CCII
MASS

About CCII Cohen Circle Acquisition Corp. II Class A Ordinary Shares

Cohen Circle Acquisition Corp II is a blank check company.

About MASS 908 Devices Inc.

908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.

Share on Social Networks: